FI954946L - Kinoksaliinit, menetelmä niiden valmistamiseksi ja niiden käyttö - Google Patents

Kinoksaliinit, menetelmä niiden valmistamiseksi ja niiden käyttö Download PDF

Info

Publication number: FI954946L
Authority: FI; Finland
Prior art keywords: quinoxalines; preparation
Prior art date: 1994-10-19

Application number

FI954946A

Other languages

English (en)

Swedish (sv)

Other versions

FI954946A0 (fi

Inventor

Manfred Dr Roesner

Uta-Maria Billhardt-Troughton

Reinhard Dr Kirsch

Joerg-Peter Dr Kleim

Christoph Dr Meichsner

Guenther Dr Ries

Irvin Dr Winkler

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-19

Filing date

1995-10-17

Publication date

1996-04-20

1995-10-17 Application filed by Hoechst Ag filed Critical Hoechst Ag

1995-10-17 Publication of FI954946A0 publication Critical patent/FI954946A0/fi

1996-04-20 Publication of FI954946L publication Critical patent/FI954946L/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Dental Preparations (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Compounds Of Unknown Constitution (AREA)

FI954946A 1994-10-19 1995-10-17 Kinoksaliinit, menetelmä niiden valmistamiseksi ja niiden käyttö FI954946L (fi)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4437406A DE4437406A1 (de)	1994-10-19	1994-10-19	Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (2)

Publication Number	Publication Date
FI954946A0 FI954946A0 (fi)	1995-10-17
FI954946L true FI954946L (fi)	1996-04-20

Family

ID=6531202

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI954946A FI954946L (fi)	1994-10-19	1995-10-17	Kinoksaliinit, menetelmä niiden valmistamiseksi ja niiden käyttö

Country Status (28)

Country	Link
US (1)	US5723461A (fi)
EP (1)	EP0708093B1 (fi)
JP (1)	JPH08225544A (fi)
KR (1)	KR960014108A (fi)
CN (1)	CN1094930C (fi)
AT (1)	ATE198747T1 (fi)
AU (1)	AU708293B2 (fi)
BR (1)	BR9504456A (fi)
CA (1)	CA2160859A1 (fi)
CZ (1)	CZ271295A3 (fi)
DE (2)	DE4437406A1 (fi)
DK (1)	DK0708093T3 (fi)
ES (1)	ES2154311T3 (fi)
FI (1)	FI954946L (fi)
GR (1)	GR3035673T3 (fi)
HK (1)	HK1011988A1 (fi)
HR (1)	HRP950524B1 (fi)
HU (1)	HUT73485A (fi)
IL (1)	IL115641A0 (fi)
MY (1)	MY132057A (fi)
NO (1)	NO306615B1 (fi)
NZ (1)	NZ280258A (fi)
PL (1)	PL184860B1 (fi)
PT (1)	PT708093E (fi)
SI (1)	SI9500329A (fi)
SK (1)	SK128495A3 (fi)
TW (1)	TW328954B (fi)
ZA (1)	ZA958783B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6369057B1 (en) *	1991-04-15	2002-04-09	Aventis Pharma Deutschland Gmbh	Quinoxalines, processes for their preparation and their use
US6015800A (en) *	1997-09-03	2000-01-18	Warner-Lambert Company	Substituted quinoxaline-2-ones as glutamate receptor antagonists
WO1999025327A2 (en) *	1997-11-14	1999-05-27	Warner-Lambert Company	Small molecule intervention in hiv-1 replication
GB9901795D0 (en) *	1999-01-28	1999-03-17	Glaxo Group Ltd	Chemical compounds
GB9911887D0 (en) *	1999-05-21	1999-07-21	Glaxo Group Ltd	Methods and medicaments for post exposure prophylaxis of an hiv infection
WO2002087500A2 (en) *	2001-04-27	2002-11-07	Newbiotics, Inc.	Viral enzyme activated prototoxophores and use of same to treat viral infections
WO2005018531A2 (fr) *	2003-08-26	2005-03-03	'chemical Diversity Research Institute', Ltd.	Compositions pharmaceutiques, composes azo-heterocycliques et procedes de fabrication et d'utilisation correspondants
US7351709B2 (en) *	2004-06-09	2008-04-01	Wyeth	Estrogen receptor ligands
BR112014026703B1 (pt)	2012-04-24	2022-10-25	Vertex Pharmaceuticals Incorporated	Inibidores de dna-pk e seus usos, composição farmacêutica e seus usos, e método de sensibilização de uma célula
HRP20211855T1 (hr)	2013-03-12	2022-03-04	Vertex Pharmaceuticals Incorporated	Inhibitori dnk-pk
LT3424920T (lt)	2013-10-17	2020-08-10	Vertex Pharmaceuticals Incorporated	(s)-n-metil-8-(1-((2`-metil-[4,5`-bipirimidin]-6-il)amino)propan-2-il)chinolin-4-karboksamido ir jo deuterintų darinių, kaip dnr-pk inhibitorių, bendri kristalai
KR20190062485A (ko)	2016-09-27	2019-06-05	버텍스 파마슈티칼스 인코포레이티드	Dna-손상제 및 dna-pk 저해제의 조합을 사용한 암 치료 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0509398B1 (de) *	1991-04-15	2001-09-19	Aventis Pharma Deutschland GmbH	Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4342024A1 (de) *	1993-12-09	1995-06-14	Hoechst Ag	Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid

1994
- 1994-10-19 DE DE4437406A patent/DE4437406A1/de not_active Withdrawn
1995
- 1995-10-12 DK DK95116094T patent/DK0708093T3/da active
- 1995-10-12 DE DE59508969T patent/DE59508969D1/de not_active Expired - Fee Related
- 1995-10-12 ES ES95116094T patent/ES2154311T3/es not_active Expired - Lifetime
- 1995-10-12 PT PT95116094T patent/PT708093E/pt unknown
- 1995-10-12 AT AT95116094T patent/ATE198747T1/de not_active IP Right Cessation
- 1995-10-12 EP EP95116094A patent/EP0708093B1/de not_active Expired - Lifetime
- 1995-10-15 IL IL11564195A patent/IL115641A0/xx unknown
- 1995-10-16 TW TW084110841A patent/TW328954B/zh active
- 1995-10-17 MY MYPI95003112A patent/MY132057A/en unknown
- 1995-10-17 CZ CZ952712A patent/CZ271295A3/cs unknown
- 1995-10-17 AU AU34316/95A patent/AU708293B2/en not_active Ceased
- 1995-10-17 FI FI954946A patent/FI954946L/fi unknown
- 1995-10-17 NZ NZ280258A patent/NZ280258A/en unknown
- 1995-10-17 SK SK1284-95A patent/SK128495A3/sk unknown
- 1995-10-17 US US08/544,290 patent/US5723461A/en not_active Expired - Fee Related
- 1995-10-18 HU HU9503005A patent/HUT73485A/hu unknown
- 1995-10-18 CN CN95120372A patent/CN1094930C/zh not_active Expired - Fee Related
- 1995-10-18 ZA ZA958783A patent/ZA958783B/xx unknown
- 1995-10-18 CA CA002160859A patent/CA2160859A1/en not_active Abandoned
- 1995-10-18 HR HR950524A patent/HRP950524B1/xx not_active IP Right Cessation
- 1995-10-18 KR KR1019950035876A patent/KR960014108A/ko not_active Abandoned
- 1995-10-18 NO NO954139A patent/NO306615B1/no not_active IP Right Cessation
- 1995-10-18 PL PL95311016A patent/PL184860B1/pl unknown
- 1995-10-19 SI SI9500329A patent/SI9500329A/sl unknown
- 1995-10-19 BR BR9504456A patent/BR9504456A/pt not_active IP Right Cessation
- 1995-10-19 JP JP7271019A patent/JPH08225544A/ja active Pending
1998
- 1998-12-12 HK HK98113241A patent/HK1011988A1/xx not_active IP Right Cessation
2001
- 2001-03-30 GR GR20010400523T patent/GR3035673T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL115641A0 (en)	1996-01-19
AU708293B2 (en)	1999-07-29
ZA958783B (en)	1996-05-09
MY132057A (en)	2007-09-28
TW328954B (en)	1998-04-01
HRP950524B1 (en)	2002-06-30
SI9500329A (en)	1996-04-30
CZ271295A3 (en)	1996-08-14
HK1011988A1 (en)	1999-07-23
JPH08225544A (ja)	1996-09-03
PT708093E (pt)	2001-06-29
GR3035673T3 (en)	2001-06-29
NZ280258A (en)	1997-09-22
NO954139D0 (no)	1995-10-18
PL311016A1 (en)	1996-04-29
CN1094930C (zh)	2002-11-27
HRP950524A2 (en)	1997-10-31
BR9504456A (pt)	1997-05-20
CA2160859A1 (en)	1996-04-20
SK128495A3 (en)	1996-06-05
NO306615B1 (no)	1999-11-29
PL184860B1 (pl)	2003-01-31
EP0708093B1 (de)	2001-01-17
CN1135483A (zh)	1996-11-13
NO954139L (no)	1996-04-22
EP0708093A1 (de)	1996-04-24
ES2154311T3 (es)	2001-04-01
DE59508969D1 (de)	2001-02-22
FI954946A0 (fi)	1995-10-17
HU9503005D0 (en)	1995-12-28
HUT73485A (en)	1996-08-28
DK0708093T3 (da)	2001-04-30
ATE198747T1 (de)	2001-02-15
AU3431695A (en)	1996-05-02
KR960014108A (ko)	1996-05-22
US5723461A (en)	1998-03-03
DE4437406A1 (de)	1996-04-25

Similar Documents

Publication	Publication Date	Title
FI955235L (fi)	1996-05-03	Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
EE03568B1 (et)	2001-12-17	Bensimidasooli derivaadid, nende valmistamismeetod ja kasutamine
EE03482B1 (et)	2001-08-15	Kinasoliiniderivaadid, nende valmistamismeetod ja kasutamine
EE03231B1 (et)	1999-10-15	Tetratsüklilised derivaadid, nende valmistamismeetod ja kasutamine
EE03338B1 (et)	2001-02-15	Tromboosivastane ravim, selle valmistamise protsess ja kasutamine
EE9700044A (et)	1997-08-15	Heteroarüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid.
EE9700153A (et)	1998-02-16	Heterotsükliga kondenseerunud püridiinid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
FI964311L (fi)	1996-10-25	Bifunktionaalinen proteiini, valmistus ja käyttö
EE9900014A (et)	1999-08-16	Erütromütsiinid ja nende valmistamise protsess
EE03528B1 (et)	2001-10-15	Valatsükloviirvesinikkloriid, selle valmistamismeetod ja kasutamine
CY2013003I1 (el)	2014-07-02	Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
FI952679L (fi)	1995-12-04	Uusia seoksia, menetelmä niiden valmistamiseksi sekä niiden käyttö päällystyksiin
EE9700020A (et)	1997-08-15	Heteroaatomit sisaldavad tsülopentaanpüridüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
EE04721B1 (et)	2006-10-16	Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
FI951468L (fi)	1995-10-01	Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
EE9800302A (et)	1999-02-15	Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat
FI951817L (fi)	1995-10-16	Orgonaluminoksituote, sen valmistus ja käyttö
FI951132L (fi)	1995-09-15	Polyamidi-oligonukleotidijohdoksia, niiden valmistus ja niiden käyttö
FI954946L (fi)	1996-04-20	Kinoksaliinit, menetelmä niiden valmistamiseksi ja niiden käyttö
FI972264L (fi)	1998-11-28	Betaiinituote, menetelmä sen valmistamiseksi, ja sen käyttö
NO983954L (no)	1999-03-01	Triazintiolderivat med perfluorgruppe, fremgangsmÕte for fremstilling og anvendelse av dette
EE04398B1 (et)	2004-12-15	Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiin-10-oolid, nende valmistamise meetod ja kasutamine ravimitena
EE03996B1 (et)	2003-04-15	Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
NO972239L (no)	1997-07-16	Ny replikasjonsprosess
FI953956A0 (fi)	1995-08-23	2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä